Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zimmer Biomet Holdings Inc ZBH

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.


NYSE:ZBH - Post by User

Post by whytestockson Feb 08, 2024 10:00pm
39 Views
Post# 35871541

Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Fi

Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Fi
News; $ZBH Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial ResultsZimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results PR Newswire Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency 1 basis Fourth quarter diluted earnings per share were $2.01 ; adjusted 1 dilut...ZBH - Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results

<< Previous
Bullboard Posts